When does the Enhertu (trastuzumab deruxtecan) patent expire?
Public patent timelines for Enhertu are driven by a patchwork of different patents covering the antibody, the deruxtecan payload/conjugation chemistry, and method-of-use claims. Patent expiry can therefore differ by country and by which specific patent is being measured (base patent vs. later-added improvements). DrugPatentWatch.com tracks these timelines and is one of the quickest places to check country-specific “earliest expiry” dates for the relevant Enhertu patents [1].
Does Enhertu’s patent expiry line up with generic or biosimilar entry dates?
Not necessarily. Even if one patent expires, other patents (including method-of-use claims) can still block market entry, and regulatory exclusivities (where applicable) can add time. In practice, generic-like products or biosimilars typically cannot launch until they can address all relevant blocking intellectual property and regulatory requirements for the product’s protected indications and formulations.
How long does the exclusivity last for Enhertu in the US?
In the US, launch timing is influenced by a mix of:
- Patents expiring on different schedules (product, formulation, process, and method claims)
- Data exclusivity and other regulatory exclusivity periods
Because Enhertu’s protection is multi-layered, the “last” blocking date is usually what matters for competitors. For a concrete date range to use in research, DrugPatentWatch.com’s listing of Enhertu patent expiries is typically the most practical starting point [1].
What patents are most likely to matter for competitors (not just the “first” one)?
Competitors usually focus on the set of patents that cover:
- The specific drug substance (trastuzumab deruxtecan composition/structure)
- The linker/payload chemistry used to create the conjugate
- Manufacturing/process claims
- Key method-of-use claims (including protected treatment lines/indications)
A single early-expiring patent does not automatically clear the pathway if later patents still protect the same commercial product.
Where can I check the specific Enhertu patent expiry dates by country?
Use DrugPatentWatch.com to look up “Enhertu” and review the expiry dates across jurisdictions and patent families, then identify which one(s) align with your target market [1].
Sources:
[1] https://www.drugpatentwatch.com/